An increasing number of AIDS patients have been noted to suffer severe recurrent aphthous stomatitis (RAS), a condition often associated with high morbidity that remains unresponsive to conventional therapeutic interventions. In two cases thalidomide was administered to successfully treat AIDS patients with RAS. Both patients experienced complete abatement of pain shortly after therapy was initiated. Ulcerations that were present for months resolved after three or four weeks of thalidomide therapy without any adverse effects. Thalidomide appears to be an effective agent for the treatment of severe RAS unresponsive to traditional therapies.
DretlerRH, RausherDB. Giant esophageal ulcer healed with steroid therapy in an AIDS patient.Rev Infect Dis1989; 11: 7689.
4.
BachMC, HowellDA, ValentiAJ, SmithTJ, WinslowDL. Aphthous ulceration of the gastrointestinal tract in patients with the acquired immunodeficiency syndrome (AIDS).Ann Intern Med1990; 112: 4656.
5.
BachMC, ValentiAJ, HowellDA, SmithTJ. Odynophagia from aphthous ulcers of the pharynx and esophagus in the acquired immunodeficiency syndrome (AIDS).Ann Intern Med1988; 109: 3389.
6.
GreenspanJS, GreenspanD, WinklerJR. Diagnosis and management of the oral manifestations of HIV infection and AIDS.Infect Dis Clin North Am1988; 2: 37385.
7.
BurleyD.Is thalidomide to blame? (letter)Br J Med1961; 1: 130.
8.
MascaroJM, LechaM, TorrasH.Thalidomide in the treatment of recurrent, necrotic, and giant mucocutaneous aphthae and aphthosis.Arch Dermatol1979; 115: 6367.
PowellRJ, AllenBR, JenkinsJSInvestigation and treatment of orogenital ulceration; studies on a possible mode of action of thalidomide.Br J Dermatol1985; 113(suppl 28): 1414.
11.
KurkcuogluM, AtakanN, EskiogluM.Thalidomide in the treatment of recurrent necrotic mucocutaneous aphthae (letter).Br J Dermatol1985; 112: 632.
12.
GrinspanD.Significant response of oral aphthosis to thalidomide treatment.J Am Acad Dermatol1985; 12: 8590.
13.
MoncadaB, BaramdaML, Gonzales-AmaroR, UribanaR, LoredoCE,. Thalidomide—effect on T cell subsets as a possible mechanism of action.Int J Lepr Other Mycobact Dis1985; 52: 2015.
